Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The US FDA has handed a supplemental approval to Merck Animal Health for its Estrumate (cloprostenol injection) reproductive injectable for cows.
European authorities have approved MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) for the treatment of ear mites in cats.
European authorities have paved the way for an extension to Boehringer Ingelheim Animal Health's top-selling NexGard antiparasitic brand.
Zoetis has gained a significant boost in the run-up to introducing a new three-way antiparasitic blockbuster product after receiving the green light from European authorities.
The US FDA has approved Zoetis' ProHeart 12 injectable heartworm prevention for dogs.
Bayer Animal Health's Advocate Spot-on has received a positive opinion for new indications in cats in the EU.
The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market.
European authorities have paved the way for Virbac to gain authorization of Evicto – a generic antiparasitic for cats and dogs.
European authorities have recommended MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) be approved for treating ear mites in cats.
Bayer Animal Health has further increased its pet portfolio in China by launching its top-selling product – Advantage – in the country.
Zoetis received three approvals from the Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) in 2018, bolstering its position as the firm with the most new products in Japan over the last 10 years.
Zoetis and Irish generics specialist Chanelle Pharmaceuticals have both recently gained authorizations from the European Medicines Agency (EMA) for companion animal antiparasitics.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.